The market for stem cell products and technologies is a rapidly evolving industry, largely because stem cells are a relatively recent, yet highly lucrative, discovery. While the first mouse embryonic stem cells were derived from embryos in 1981, it was not until 1995 that the first successful culturing of embryonic stem cells from non-human primates occurred and not until November 1998 that a technique was developed to isolate and grow embryonic stem cells from human blastocysts. In 2006, induced pluripotent stem cells were produced for the first time from mouse cells, and, in 2007, they were produced from human cells. Furthermore, it was not until 2008 that the first full transplant of a human organ grown from adult stem cells was performed when a section of a trachea was transplanted into a woman in Spain.











